Ftse Mib
34.650,95
0,91%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
60.491,82
-4,06%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSX Trilogy International Partners Inc (TRL) Trilogy International Partners Inc (TRL) Notizie

TRL

Trilogy International Pa... (TRL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:TRL
DataOraFonteTitoloSimboloCompagnia
07/02/202218:15PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TRL.WTTSX:TRLTrilogy International Partners Inc
07/02/202218:12PR Newswire (Canada)IIROC Trading Halt - TRL.WTTSX:TRLTrilogy International Partners Inc
07/10/202114:18PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - TRLTSX:TRLTrilogy International Partners Inc
07/10/202114:16PR Newswire (Canada)IIROC Trade Resumption - TRLTSX:TRLTrilogy International Partners Inc
06/10/202121:10PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TRLTSX:TRLTrilogy International Partners Inc
06/10/202121:09PR Newswire (Canada)IIROC Trading Halt - TRLTSX:TRLTrilogy International Partners Inc
15/02/201923:12PR Newswire (US)Phoenix Tower International expands footprint in South America with acquisition of 600 wireless communication tower sites fro...TSX:TRLTrilogy International Partners Inc
08/09/201723:45PR Newswire (Canada)S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian IndicesTSX:TRLTrilogy International Partners Inc
08/09/201723:42PR Newswire (Canada)S&P Dow Jones Indices annonce des modifications aux indices canadiens S&P/TSXTSX:TRLTrilogy International Partners Inc
16/03/201512:30PR Newswire (Canada)Endo Pharmaceuticals Announces the Launch of NATESTO™ (testosterone nasal gel), the First and Only Nasal Gel for Testostero...TSX:TRLTrilogy International Partners Inc
09/12/201413:00PR Newswire (Canada)Endo Completes Acquisition of Rights to Natesto™ Testosterone Nasal GelTSX:TRLTrilogy International Partners Inc
01/12/201414:34InvestorsHub NewsWireEDISON EQUITY RESEARCH - TRIMEL PHARMACEUTICALSTSX:TRLTrilogy International Partners Inc
06/08/201406:27InvestorsHub NewsWireTrimel Pharmaceuticals - Seeking positive EBITDA with EstraceTSX:TRLTrilogy International Partners Inc
30/07/201415:15Marketwired CanadaTrimel Completes Private Placement of Common SharesTSX:TRLTrilogy International Partners Inc
28/07/201416:12InvestorsHub NewsWireTrimel Pharmaceuticals - A closer look at Tefina Phase II FOD resultsTSX:TRLTrilogy International Partners Inc
26/07/201400:31PR Newswire (Canada)Update to Early Warning Report for Trimel Pharmaceuticals CorporationTSX:TRLTrilogy International Partners Inc
17/07/201419:53PR Newswire (Canada)L’OCRCVM permet la reprise de la négociation - TRLTSX:TRLTrilogy International Partners Inc
17/07/201419:40Marketwired CanadaTrimel Pharmaceuticals Acquires Canadian Rights to Estrace®TSX:TRLTrilogy International Partners Inc
18/06/201421:00MarketwiredTrimel to Present at the JMP Securities Healthcare ConferenceTSX:TRLTrilogy International Partners Inc
16/06/201421:20MarketwiredTrimel to Present at the 2014 Bloom Burton & Co. Healthcare Investor ConferenceTSX:TRLTrilogy International Partners Inc
16/06/201412:00MarketwiredTrimel Reports Additional Results From Tefina(TM) Phase II Clinical TrialTSX:TRLTrilogy International Partners Inc
13/06/201401:41MarketwiredTrimel Announces Voting Results for 2014 Annual General and Special Shareholders' MeetingTSX:TRLTrilogy International Partners Inc
29/05/201403:06PR Newswire (US)Trimel Receives FDA Approval for Natesto(TM) Nasal Gel to Treat Men with Low TestosteroneTSX:TRLTrilogy International Partners Inc
29/05/201401:28PR Newswire (Canada)Trimel Receives FDA Approval for Natesto™ Nasal Gel to Treat Men with Low TestosteroneTSX:TRLTrilogy International Partners Inc
28/05/201412:30PR Newswire (US)Trimel Pharmaceuticals Announces Positive Phase II Results for Tefina™TSX:TRLTrilogy International Partners Inc
08/05/201423:29MarketwiredTrimel Provides Corporate Update and First Quarter 2014 Financial ResultsTSX:TRLTrilogy International Partners Inc
02/05/201421:37MarketwiredTrimel to Report First Quarter 2014 Results and Host Conference Call to Update InvestorsTSX:TRLTrilogy International Partners Inc
06/03/201401:33MarketwiredTrimel Reports Fourth Quarter and Full Year 2013 Financial ResultsTSX:TRLTrilogy International Partners Inc
27/02/201422:45MarketwiredTrimel to Report Financial Results for 2013 and Host Conference Call to Update InvestorsTSX:TRLTrilogy International Partners Inc
21/02/201421:44MarketwiredTrimel Announces Closing of $10.5 Million Private Placement of Common SharesTSX:TRLTrilogy International Partners Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:TRL

La tua Cronologia

USOTC
AVSFY
Avi (PK)
BOV
TTEN3M
3TENTOS ON NM ON
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network